Oppenheimer downgraded NICE from Outperform to Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/17/2025 | $176.00 | Neutral | Cantor Fitzgerald |
| 12/19/2024 | $215.00 → $200.00 | Buy → Hold | Jefferies |
| 11/15/2024 | Outperform → Perform | Oppenheimer | |
| 11/14/2024 | Overweight → Neutral | Piper Sandler | |
| 4/23/2024 | $285.00 | Buy | Rosenblatt |
| 3/13/2024 | $250.00 → $300.00 | Neutral → Buy | DA Davidson |
| 1/30/2024 | $300.00 | Outperform | Northland Capital |
| 10/16/2023 | $225.00 → $220.00 | Equal-Weight → Overweight | Morgan Stanley |